Back
Milestone Pharmaceuticals 10K Form
Sell
27
MIST
Milestone Pharmaceuticals
Last Price:
$1.77
Seasonality Move:
-17.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-12 | 10Q | MIST/Milestone Pharmaceuticals Quarterly |
2020-05-14 | 10Q | MIST/Milestone Pharmaceuticals Quarterly |
2020-03-06 | 10K | MIST/Milestone Pharmaceuticals Annual |
2019-11-13 | 10Q | MIST/Milestone Pharmaceuticals Quarterly |
2019-08-13 | 10Q | MIST/Milestone Pharmaceuticals Quarterly |
2019-06-19 | 10Q | MIST/Milestone Pharmaceuticals Quarterly |
Receive MIST News And Ratings
See the #1 stock for the next 7 days that we like better than MIST
MIST Financial Statistics
Sales & Book Value
Annual Sales: | $1M |
---|---|
Cash Flow: | $-7M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.45 |
Price / Book: | 3.96 |
Profitability
EPS (TTM): | -0.81000 |
---|---|
Net Income (TTM): | $-42.8M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Milestone Pharmaceuticals Earnings Forecast
Key Milestone Pharmaceuticals Financial Ratios
-
The Research & Development expenses have been 3,105.20% of Revenue.
-
The Interest Expense is -4.28% of Operating Income.
-
The Net Earning history of MIST is -5,968.50% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 2 years.
Milestone Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | MIST |
CUSIP: | 59935V |
Website: | milestonepharma.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
MIST Technical Analysis vs Fundamental Analysis
Sell
27
Milestone Pharmaceuticals (MIST)
is a Sell
Is Milestone Pharmaceuticals a Buy or a Sell?
-
Milestone Pharmaceuticals stock is rated a SellThe current Milestone Pharmaceuticals [MIST] share price is $1.79. The Score for MIST is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.